FIELD: medicine. SUBSTANCE: method involves administering prospidine into lymphatic system at a dose of 10000-100000 units of action during one procedure each second day 10-15 injections for treatment course. Lidase is to be optionally injected in the amount of 16-48 units of action, prospidine and proteolysis inhibitor are administered in lymphotropic mode. EFFECT: normalized lymphatic system function. 2 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENT WITH KAPOSI'S SARCOMA IDIOPATHIC TYPE | 1998 |
|
RU2140270C1 |
METHOD FOR TREATING REITER DISEASE | 2000 |
|
RU2175550C1 |
METHOD FOR TREATING THE CASES OF PSORIATIC ERYTHRODERMIA | 1996 |
|
RU2133610C1 |
METHOD FOR OPTIMIZING FUNCTIONS OF LYMPH NODES BY METHOD OF CLOSED NON-INVASIVE LAVAGE OF LYMPHATIC SYSTEM | 2021 |
|
RU2777208C1 |
ARTHROSIS TREATMENT METHOD | 1998 |
|
RU2135224C1 |
METHOD OF TREATING T-CELL LYMPHOMAS AND KAPOSIS'S SARCOMA | 2009 |
|
RU2401671C1 |
METHOD FOR MODIFYING PHOTODYNAMIC THERAPY | 2010 |
|
RU2449821C1 |
METHOD FOR TREATING LARYNX PAPILLOMATOSIS IN CHILDREN | 1995 |
|
RU2111755C1 |
METHOD FOR TREATING THE CASES OF CHRONIC URINARY TRACT INFLAMMATION DISEASE IN CHILDREN | 2001 |
|
RU2199358C2 |
METHOD FOR TREATING MALIGNANT BONE TUMORS AND OSTEOLYTIC METASTASES IN BONE | 1997 |
|
RU2144398C1 |
Authors
Dates
1999-05-27—Published
1996-02-29—Filed